A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition
Article in npj Precision Oncology (January 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in npj Precision Oncology (January 2024)
Preprint in Research Square (November 2023)
Article in Drug Resistance Updates (August 2022)